MedCity News December 9, 2024
Cala Health closed a $50 million funding round. The Silicon Valley-based company sells an FDA-cleared wearable device that temporarily relieves hand tremors in people with essential tremor and Parkinson’s disease.
On Monday, a Silicon Valley-based bioelectronic medicine company raised tens of millions of dollars to help the more than 7 million Americans who struggle with essential tremor (ET).
The company, named Cala Health, closed a $50 million funding round co-led by Vertex Growth Fund and Nexus NeuroTech Ventures. All of the company’s existing investors also participated in the round, including GV, Johnson & Johnson, Lux Capital, OSF Ventures and Ascension Ventures.
Cala was founded in 2014 as a Stanford University spinout. Its main goal is to give patients a better...
Today's Sponsors
Today's Sponsor